Associate at 3 point HRM
Views:258 Applications:9 Rec. Actions:Recruiter Actions:0
Medical Advisor/Pharmacovigilance Scientist (2-7 yrs)
Responsibilities for pharmacovigilance scientist
- Act as core member for assigned products
- Ensure timely, quality reports/safety analyses related to core deliverables with oversight as appropriate
- Provide complete PVRM product life-cycle support for assigned product(s)
- Serve as Pharmacovigilance resource to clinical and post-marketing cross functional teams
- Collaborate with clinical and post-marketing teams to foster communication of potential safety concerns
- Participate in the development of protocols, annual updates to the compound-specific safety reference documents (Investigator's Brochure, core safety information, etc), contribute and review Informed Consent Forms (ICF), ensure safety oversight in cooperation/leadership of the clinical trial medical team, represent PVRM in SAE reconciliation, final CSR narrative writing/review and contribute to the review of the final clinical safety report (CSR)
- Perform study-start activities, as necessary
- Acts as primary author/reviewer for assigned product aggregate periodic reports such as the DSUR, PADER, PBRER and others
- Perform on-going individual case quality review of representing company review in accordance with study Safety Management Plans, Safety exchange agreements and Merrimack SOPs
Qualifications for pharmacovigilance scientist
- Knowledge and experience in infectious diseases and/or vaccines is preferred
- Ability to effectively present to cross-functional teams is required. Drug & Product Safety Science
- Ability to effectively present to cross-functional teams is required
- Provide clinical, regulatory and technical pharmacovigilance expertise to DS&E medical function & DS&E leadership
- Lead the preparation of aggregate safety reports for newly launched Novartis products to meet regulatory requirements
- Alert the Medical Safety Physicians to potential safety issues recognized through single case medical review or aggregated data sets